DOCSLIB.ORG

Apollo Hospitals Readytovaccinate 1 M People Daily

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Apollo Hospitals Readytovaccinate 1 M People Daily PUNE, FRIDAY, DECEMBER 11, 2020 FOLLOW US ON TWITTER & FACEBOOK. APP AVAILABLE ON APP STORE & PLAYSTORE WWW.FINANCIALEXPRESS.COM VOL. XI NO. 269, 16 PAGES, `6.00PUBLISHEDFROM:AHMEDABAD,BENGALURU,CHANDIGARH, CHENNAI,HYDERABAD,KOCHI,KOLKATA,LUCKNOW,MUMBAI, NEWDELHI,PUNE READ TO LEAD Presented by We owe this success to you ! TiE Global Summit 2020 kicked off with stupendous success, unravelling new avenues, the world is keen to explore. 45,000+ A Big Thank you ! participants, entrepreneurs, investors, mentors and leaders from across the globe come together to create & sustain a For making the World’s Largest Entrepreneurship Summit strong ecosystem for entrepreneurial success. A thunderous success ! This is where future possibilities unfold and future is scripted. SRI VENKAIAH NAIDU Honorable Vice President of India Former Chairman BILL GATES NASSCOM Co-founder, Microsoft Honoured with Lifetime Achievement Award TiE Global Summit 2020 JANMEJAYA Its an honour to receive this prestigious award from TiE SINHA SelectUSA,U.S. Chairman, Boston Department of Commerce Consulting Group India DR. OLA BROWN Founder of the Flying Doctors Healthcare Investment Group As a First Generation Entrepreneur Mr. Bill Gates has created a remarkable impact not Mr. Bill Gates is a Visionary Entrepreneur who has overcome various challenges and only on the global economy but also has become an inspiration to many entrepreneurs failures to create a new world, and he has leveraged success to tackle health and through generations, and the fact that he continues to give back to society. What he poverty issues worldwide which are overlooked by society.He democratized the entire has achieved is commendable. My Heartiest Congratulations to Mr. Bill Gates on being TiE Global Chair TGS Chair IT and Computer Technology ecosystem. He is a living legend and a role model for awarded the Lifetime Achievement Award. every entrepreneur. My Personal and Hearty Congratulations to Mr. Bill Gates on being awarded the Lifetime Achievement Award. Chairman Indian Blockchain Standards Committee Pune FRIDAY, DECEMBER 11, 2020 WWW.FINANCIALEXPRESS.COM 2 FINANCIAL EXPRESS Amrutanjan Health Care Limited CIN: L24231TN1936PLC000017 Regd. Office: No103 (Old No.42-45), Luz Church Road, Mylapore, Chennai 600 004 Tel : 044-2499 4465 Fax 044-2499 4585 Website : www.amrutanjan.com COMPANY NOTICE Notice is hereby given that the following Share Certificate bearing distinctive numbers given below standing registered in the favour of Mr. PRAKASHCHANDRA PRABHU Hunder Folio no:P0000255 has been reported lost/misplaced. Share Certificate No(s) No of shares Distinctive Numbers 968 1340 866725-868064 Duplicate of the said Share Certificate(s) will be issued, if no objection is lodged with the Registered Office of the Company within fifteen days from the date of publication. For AMRUTANJAN HEALTH CARE LIMITED Sd/- Place: Chennai (M. Srinivasan) Date: 10/12/2020 Company Secretary & Compliance Officer ''IMPORTANT'' Whilst care is taken prior to acceptance of advertising copy,it is notpossibletoverify its contents. The Indian Express (P) Limited cannot be held responsible for such contents, nor for any loss or damage incurred as a result of transactions with companies, associations or individuals advertising in its newspapers or Publications. We therefore recommend that readers make necessary inquiries before sending any monies or entering into any agreements with advertisers or otherwise acting on an advertisement in any manner whatsoever. K SUGAR C AND P IND COR NOTICE Pune OPINION, P8 COMPANIES, P6 INTERNATIONAL, P10 EDITORIAL BY 2027 TEST LAUNCH 75% of districts extreme DRDO's quantum Walmart to increase SpaceX's Starship communication success climate hotspots; local quite significant, now exports from India prototype explodes climate planning needed focus on NM-QTA to $10 bn each year on landing PUNE, FRIDAY, DECEMBER 11, 2020 FOLLOW US ON TWITTER & FACEBOOK. APP AVAILABLE ON APP STORE & PLAYSTORE WWW.FINANCIALEXPRESS.COM VOL. XI NO. 269, 16 PAGES, `6.00PUBLISHEDFROM:AHMEDABAD,BENGALURU,CHANDIGAR H,CHENNAI,HYDERABAD,KOCHI,KOLKATA,LUCKNOW,MUM BAI,NEWDELHI,PUNE READ TO LEAD SENSEX: 45,959.88 ▼ 143.62 NIFTY: 13,478.30 ▼ 50.80 NIKKEI 225: 26,756.24 ▼ 61.70 HANG SENG: 26,410.59 ▼ 92.25 `/$: 73.67 ▼ 0.10 `/€: 89.17 ▲ 0.03 BRENT: $49.52 ▲ $0.66 GOLD: `49,049 ▼ `456 IN THE NEWS FARMERS’ PROTESTS ● COVID-19 CAPITAL NEEDS CCI raids offices Ready to PSBs told to tap mkts aggressively of LafargeHolcim, Delhi blockade soon; vaccinate 1 m other cement firms Massive infusion daily:Apollo More infusion likely Barring THE COMPETITION Commi- (` cr) 106,000 SBI, BoB & ssion of India (CCI) on Wed- APOLLOHOSPITALS,thecoun- in March after 88,139 Canara, govt holds nesday conducted raids at can still talk,says govt try’s largest hospital chain,says evaluating Q3 results over 80% in all 70,000 the offices of some cement it’sreadytoadministeronemil- other PSBs due companies, including The unions added that they lioncoronavirusvaccinedosesa Will block railway to regular LafargeHolcim, reports PTI. would block the Jaipur-Delhi day,butthegovernmenthasnot BANIKINKAR PATTANAYAK infusion According to some reports, tracks if need be, andtheDelhi-Agraexpressways made clearhowvaccineswill be New Delhi, December 10 25,000 25,000 the CCI also conducted “onorbeforeDecember12,”and distributedandwhetherprivate 20,000 raids at offices ofAditya will announce date all the roads entering into the healthcare networks will be THE GOVERNMENT HAS *Outlay via Birla group’s UltraTech supplementary national capital,one-by-one,if involved, reports Bloomberg. impressed upon public-sector FY16 FY17 FY18 FY19 FY20 FY21* demand Cement, and Shree Cement. FE BUREAU theirdemandsareunmet. Apollo has so fartrained 6,000 banks (PSBs) to raise capital New Delhi, December 10 Farmer leader Shiv Kumar staff to give out jabs across its from the markets more IRCTC OFS: Issue “No law is completely Kakkatoldmediaherethatthere network of 71 hospitals, hun- aggressively,takingadvantage At the same time,it is plan- assessing their financial per- subscribed two DECLARING THAT THEY are bad. We are still ready to wasnothingnewinthegovern- dredsofclinicsandthousandsof of abundant liquidity, and ning to finalise by late Febru- formance in the third quarter steadfastly on the warpath, discuss any specific ment’s proposals sent to them pharmacies, according to MD ensureasustainedcreditpush aryorearlyMarchthedistribu- aswell as success in fund-rais- times on Day 1 farmerunionsonThursday cat- clauses in the laws on on Wednesday, and that these SuneetaReddy. to help spur economic activi- tion of the `20,000-crore ing,sources told FE. egorically rejected the govern- was“completelyrejected”bythe ties, as lockdown curbs are capital, approved in Septem- THE OFFER-for-sale for the ment proposals to amend the which farmers have ‘Sanyukta Kisan Committee'’. Full report on Page 6 all but lifted. ber, among various PSBs after Continued on Page 4 Indian Railway Catering and three contentious agriculture- objections.” JangvirSingh,leaderof another Tourism Corp (IRCTC) got a marketinglawstheywantabro- union,however,saidtheunions good response from non- gated. Even after agriculture “There is no relation might consider if the govern- retail investors as the issue ministerNarendraSinghTomar between MSP and these mentsentanotherproposal. was subscribed nearly two said the door for discussions laws. The laws are not All the 40-odd farmers times on the first day,reports “arestillopen”andthatfurther going to impact the unionswhohavecometogether PTI. Retail investors will get changes in the laws could be current MSP under the Samyukta Kisan chance to bid for IRCTC OFS made,farmer leaders said they Morcha would discuss their on Friday,the last day for the would intensify their agitation procurement system”. strategyfurtheronSaturday. issue, DIPAM secretary —NARENDRA SINGH TOMAR against the laws with a nation- AGRICULTURE MINISTER Tuhin Kanta Pandey said. wideprotestonDecember14. Continued on Page 4 SUPREME COURT OPPORTUNITY Tatas nix Mistry plan Fintechs lending to to resolve dispute high-risk segments SHRITAMA BOSE FE BUREAU relief cannot be granted. I am Mumbai, December 10 New Delhi, December 10 opposingit,”TataSonscounsel Harish Salve told a Bench led ARMED WITH CAPITALa TATA SONS ON Thursday by the Chief Justice. Salve clutch of fintechs is moving in rejected the non-cash settle- added that if this proposal is to finance the self-employed ment offer extended by the accepted,it would leave Tata and freelancers at a timewhen ■Fintechs moving in to finance ShapoorjiPallonji(SP) groupin Sons with the problem of banks and other lenders are self-employed, small business lieu of its 18.4% stake in the minorityshareholdinginallits clamping down on unsecured owners and freelancers holdingfirm. group firms instead of the loans.The risks are high given ■Banks and large NBFCs have The SPGroup had offered a holding firm where this prob- howevenbeforethepandemic frozen unsecured lending; pro-rata division of all the lem exists today. the share of loans in the 90 some have raised income caps assetsofTataSonsaspartofthe The CJI queried if the pro- days-past-due (dpd) category ■Fintechs lending to settlement and had valued its posal is“tenable”at this stage. waselevated. businesses are tracking end stakeat`1.75lakhcrore. AstudybyEquifaxandSmall use by embedding themselves “It’s nonsense.This kind of Continued on Page 4 Industries Development Bank in the supply chain of India (Sidbi) put the ratio of ■Delinquencies
Load more

Recommended publications
  • 0 January to July 2021
    0 www.journalsofindia.com January to July 2021 SCIENCE & TECH ............................................................................................................................................................... 6 1. REUSABLE LAUNCH VEHICLE TECHNOLOGY DEMONSTRATION PROGRAMME(RLV-TD) ................................................. 6 2. GAGANYAAN MISSION ..................................................................................................................................................... 6 3. MARS ORBITER MISSION (MOM) ..................................................................................................................................... 6 4. CHANDRAYAAN MISSION................................................................................................................................................. 7 5. SOLAR MISSION ............................................................................................................................................................... 8 6. ARTEMIS ACCORD ............................................................................................................................................................ 9 7. NATIONAL MISSION ON INTERDISCIPLINARY CYBER-PHYSICAL SYSTEM (NMICPS) ....................................................... 10 8. SMART ANTI-AIRFIELD WEAPON (SAAW) ...................................................................................................................... 10 9. AQUAPONICS ................................................................................................................................................................
    [Show full text]
  • Bcpct]Ttsbc^Prc U^A Dq[XRV^^S
    6 < %()(=#%% 53%7==,>3='$()6(=#%% (#-'>3='$()6(=#%% $'()"*$+&,- %( !"# $$%& 2(*3-% (566)(37)% 3 0 4 $5 3 $1 2 0 .8 9 8 ++0 0 .:; . !" . / 01 $ %'( $) '# *' it for the last eight to nine notable achievements to its months, “where is the UN in name in the 75 years of its aking a strong case for a this joint fight. Where is the experience, including the pre- Msignificant role for India effective response.” vention of a third world war, in the United Nations, Prime Focussing on a more “we can’t deny terrorist attacks 0 Minister Narendra Modi on prominent role for India in the shook the world”. Saturday stressed the need for UN and fight against corona, “We have successfully ne of the oldest partners changes in the international the Prime Minister avoided avoided a third world war but Oof the BJP — the body and questioned its posi- making any reference to ongo- we cannot deny many wars Shiromani Akali Dal — which tion in fighting the coron- ing tension at the Line of happened, many civil wars has been with it through thick avirus pandemic. Actual Control (LAC) and happened. Terrorist attack and thin for decades, finally He also assured the global frosty ties with Pakistan in his shook the world. Blood was quit the National Democratic Q community that India will pro- 20-minute speech. He also did spilled. Those were killed were Alliance (NDA) on Saturday, vide corona vaccine to the not respond to Pakistan Prime like you and me. Children left signaling a complete political world as it is the world’s biggest Minister Imran Khan’s remarks the world prematurely,” he said.
    [Show full text]
  • Ситуация По Вакцинам От Covid-19 В Мире. Вопросы Коммуникации С Населением По Вакцинации От Covid-19
    Филиал «Научно-практический центр санитарно-эпидемиологической экспертизы и мониторинга» Ситуация по вакцинам от COVID-19 в мире. Вопросы коммуникации с населением по вакцинации от COVID-19 Алматы, 2021 г. Ситуация в мире по вакцинам против COVID-19 - Согласно данным Всемирной организации здравоохранения по состоянию на 19.01.2021 года в мире: - разрабатываются 237 вакцин-кандидатов: . из них проходят клинические стадии испытания - 64 вакцины . пре-клинические стадии проходят - 173 вакцин. используются 8 вакцин (Moderna, BioNTech / Pfizer, Oxford Biomedica и AstraZeneca, НИИ Гамалея (Спутник V), CanSino Biologics, Sinopharm (2), Sinovac / Instituto Butantan / Bio Farma). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines Вакцины в мире Экстренно введенные В фазе 3 (20) В фазе 2 (21) В фазе 1 (43) вакцины • Moderna (США) • QazCovid in(Казахстан) • Medigen (Тайвань) • VIDO (Канада) • • • • Pfizer-BioNTech (Германия) SINOVAC (Китай) Arcturus (США) Genexine (Южная Корея) • Covaxin (Индия) • Спутник V (Gamaleya РФ) • Pfizer-BioNTech (Германия) • Walvax Biotechnology (Китай) • • • • AZD1222 (Британия-Франция) Clover Biopharmaceuticals (США) Gennova Biopharmaceuticals (Индия) ChulaCov19 (Китай) • West China Hospital of Sichuan • GeneOne Life Science (Южная Корея) • Covigenix VAX-001 (Канада) University (Китай) • Soberana 1 (Куба) • Symvivo (Канада) • mRNA-1273 (США) • COVAX (Франция) • CORVax12 (США) • CVnCoV (Германия) • SpyBiotech (Англия) • Vaxart (США) • AG0302-COVID19 (Япония) • Dynavax (США) • Merck (США)
    [Show full text]
  • Coronavirus: Quello Che C'è Da Sapere – 7 Giugno 2021
    Coronavirus: quello che c’è da sapere – 7 giugno 2021 Sommario Quando è iniziata l’epidemia? ...................................................................2 Come viene diagnosticata la malattia Covid-19? ...................................23 Quando è arrivata in Italia? .......................................................................2 Che cosa sono i test sierologici? a cosa servono? ................................25 A cosa è dovuta l’infezione? .....................................................................2 Chi viene colpito dalla malattia Covid-19? ............................................25 Quanto è diffusa l’epidemia? ....................................................................2 Quanto è letale il virus? Quali sono i fattori di rischio? .........................25 Che cosa sono i coronavirus? ...................................................................2 Quali sono le conseguenze a medio e lungo termine del Covid-19? .....29 Qual è l’origine del virus? .........................................................................4 Il virus può mutare? ..................................................................................4 Esiste un vaccino? ...................................................................................31 Come si trasmette l’infezione? .................................................................9 Quali sono le terapie disponibili?............................................................46 I bambini sono più soggetti all’infezione? .............................................13
    [Show full text]
  • PAWAN GOENKA on India As an Innovation Hub
    INTERVIEW KRIS GOPALAKRISHNAN SHAASTRAMAG.ORG VOLUME 01 | EDITION 01 | MAY-JUNE 2021 | `199 SCIENCE | TECHNOLOGY | INNOVATION FUTURE VACCINES A clearer understanding of the SARS-CoV-2 virus could lead Indian biologists to develop more potent vaccines. + Gennova brings mRNA home + Mynvax: A vaccine ‘made’ for India PAWAN GOENKA on India as an innovation hub The emerging ecosystem for BIOTECH START-UPS How R.I. Sujith snuffed out COMBUSTION INSTABILITY Creating Possible For more than 30 years, Gilead has created breakthroughs once thought impossible for people living with life-threatening diseases. We are a leading biopharmaceutical company with a pioneering portfolio and ever-expanding pipeline of investigational medicines. Our commitment goes well beyond science. We innovate with the goal of eliminating barriers and providing access to healthcare for people who need it most. For more information, please visit www.gilead.com. © 2021 Gilead Sciences, Inc. SHAASTRA 2021 May-Jun 14.indd 2 5/18/21 7:26 PM 03 Letter from the Editor Contents 04 What Shaastra is about 06 News in Brief A round-up of recent advances 2021 MAY-JUN across science domains. VOLUME 01 EDITION 01 SOXWHITE / 123RF 11 Why physicists are astir Learnings from the muon g-2 experiment. 12 The ‘efficiency trap’ Guest Column: Guru Madhavan shaastramag.org Supported by the 50,000-strong alumni of IIT Madras. Editorial 14 The joy of learning science Editor Guest Column: Ramji Raghavan Hari Pulakkat Executive Editor Venky Vembu 16 The chips are up Vaccines of the future 20 A new dawn is breaking Contributing Editors K.C. Krishnadas for Indian chip design and Gauri Kamath A clearer understanding of the SARS-CoV-2 virus could lead manufacturing, but old T.V.
    [Show full text]
  • Coronavirus Vaccine Tracker
    https://nyti.ms/2MHNdRL U.S.A. World Health Coronavirus Vaccine Tracker By Carl Zimmer, Jonathan Corum and Sui-Lee Wee Updated April 5, 2021 PHASE 1 PHASE 2 PHASE 3 AUTHORIZED APPROVED ABANDONED 50 35 23 5 8 4 Vaccines Vaccines Vaccines Vaccines Vaccines Vaccines testing safety in expanded in large-scale in early or approved abandoned and dosage safety trials efficacy tests limited use for full use after trials Vaccines typically require years of research and testing before reaching the clinic, but in 2020, scientists embarked on a race to produce safe and effective coronavirus vaccines in record time. Researchers are currently testing 86 vaccines in clinical trials on humans, and 23 have reached the final stages of testing. At least 77 preclinical vaccines are under active investigation in animals. New additions and recent updates April 5 The Walter Reed Army Institute of Research enters Phase 1. April 5 Japanʼs KM Biologics begins Phase 1/2. April 2 Franceʼs OSE Immunotherapeutics enters Phase 1. March 31 The Pfizer-BioNTech vaccine is highly effective in adolescents. March 31 Some Johnson & Johnson doses are delayed by a U.S. factory mix-up. March 30 Chinaʼs Jiangsu Rec-Biotechnology enters Phase 1. March 27 Turkeyʼs Middle East Technical and Bilkent University begin Phase 1. March 25 A vaccine from Chinaʼs Zhongyianke Biotech enters Phase 2. March 23 U.S. officials question the completeness of AstraZenecaʼs trial results. March 23 Daiichi Sankyo and the University of Tokyo enter Phase 1/2. March 22 AstraZenecaʼs vaccine is found to be 79% effective in a large U.S.
    [Show full text]
  • CA January 2021 Topicwise
    Note: First few volume of target shots are bigger because we are covering news in detail with static linkages considering fresher's preparation also. Next coming volumes will be more concise Environment. 9 Pangolin 9 Dzukou Forest Fire 9 Umed Paoni Karhandla Wildlife Sanctuary 9 Sabari river 10 Asian Waterbird Census-2020 10 Nile River 11 Climate of India during 2020 11 Draft Arctic Policy of India 12 Air Pollution 13 Caracal 14 NCAVES India Forum 2021 15 Ecosystem Services 15 Antarctic Ozone Hole 16 Management Effectiveness Evaluation of Protected Areas 17 One Planet Summit 18 Sultanpur National Park 18 Khadi Prakritik Paint 19 Asian Houbara Bustard 19 Polar vortex 20 Nagi-Nakti Bird Sanctuaries 20 Harike Wetland 21 India’s costliest mushroom: 21 Indian Star Tortoise 22 Greater Adjutant Stork 22 Carbon Sequestration 23 Bandipur Tiger Reserve 24 First wildlife sanctuary exclusively for wolves 24 Mahananda Wildlife Sanctuary 24 Commission for Air Quality Management (CAQM) 25 Great Green Wall Initiative 25 Greenhouse gas emissions from man-managed grasslands 26 Green tax 26 Nilgiri Biosphere Reserve 27 SHOOLPANESHWAR WILDLIFE SANCTUARY 27 Science & Technology. 28 KSTAR ‘Artificial Sun’ Of Korea Sets World Record 28 What is anaemia? 28 Bird flu Or Avian influenza (AI) 29 JOIN Us : https://targetupsc.in/ 8830115524 1 SAHAYAK-NG 29 Satyameva Jayate: Digital Media Literacy 29 Lithium-ion Battery 30 Lightning 31 Banana Grit 32 Radiation Dazzlers (Laser Dazzlers) 33 “Atmosphere & Climate Research-Modelling Observing Systems & Services (ACROSS)”
    [Show full text]
  • 1 April 2021
    1 www.journalsofindia.com April 2021 Content 1. AGRICULTURE .......................................................................................................................................................... 6 1.1 SADABAHAR MANGO ............................................................................................................................................... 6 1.2 ROBO PLANTS ........................................................................................................................................................... 6 1.3 LARGE AREA CERTIFICATION SCHEME ....................................................................................................................... 7 1.4 MACS 1407 ............................................................................................................................................................... 7 2. ECONOMY ................................................................................................................................................................ 8 2.1 EMERGENCY CREDIT LINE GUARANTEE SCHEME (ECLGS) 3.0 ..................................................................................... 8 2.2 GLOBAL GENDER GAP REPORT .................................................................................................................................. 8 2.3 CODE ON WAGES (CENTRAL ADVISORY BOARD) RULES, 2021 .................................................................................... 9 2.4 INSURANCE OMBUDSMAN ......................................................................................................................................
    [Show full text]
  • Coronavirus: Quello Che C'è Da Sapere – 19 Luglio 2021
    Coronavirus: quello che c’è da sapere – 19 luglio 2021 Sommario Quando è iniziata l’epidemia? ......................................2 Che cosa sono i test sierologici? a cosa servono? ................................26 Quando è arrivata in Italia? ..........................................2 Chi viene colpito dalla malattia Covid-19? ............................................26 A cosa è dovuta l’infezione? .........................................2 Quanto è letale il virus? Quali sono i fattori di rischio? .........................26 Quanto è diffusa l’epidemia? ....................................................................2 Quali sono le conseguenze a medio e lungo termine del Covid-19? .....31 Che cosa sono i coronavirus? ...................................................................2 Qual è l’origine del virus? .........................................................................4 Il virus può diventare endemico?............................................................32 Il virus può mutare? ..................................................................................4 Esiste un vaccino? ...................................................................................33 Come si trasmette l’infezione? ...............................................................10 Quali sono le terapie disponibili?............................................................48 I bambini sono più soggetti all’infezione? .............................................14 Quali sono i rischi sanitari legati all’epidemia? .....................................60
    [Show full text]
  • OLYMPICS -T.P.Sreenivasan IFS (Retd.) Geographical Indications Athens to Tokyo -Dr
    AUGUST 2021 | Vol 16 | Issue 09 | Trivandrum, India Authenticity, Brevity and Clarity in Knowledge Dissemination Issue 188 Crossing the Rubicon OLYMPICS -T.P.Sreenivasan IFS (Retd.) Geographical Indications Athens to Tokyo -Dr. Raju Narayana Swamy IAS 1 India ` 50 | European Countries 5 | Singapore S$ 10 | UAE Dh 20 | USA $ 6 Dear readers, Editor’s Another edition of Executive Knowledge Lines is now with you. We at EKL always DESK endeavour to make each issue look different in its content diversity. In selection of content, we always earnestly strive to adopt a multi disciplinary approach. How far we succeed in doing that is a matter to be judged by our esteemed readers. Human life still continues to be on a different plane. Though the grip of the pandemic on mankind has been loosening with the passage of time, the threat of a third wave looms large in many parts of the world as cautioned by experts. When certain calamities befall upon the people, the onus of combating them lies as much on the State as on the citizens to the extent both can do so. Government of India has been taking a host of measures to ensure that the citizens are equipped well to face the challenge and threat posed by the growing pandemic. The citizens are being empowered with the right information and precautions as per the Health Ministry’s advisories and best efforts are on to get the entire the population vaccinated. The success of the government’s efforts depends largely on the extent of vigil and compliance on the part of the people.
    [Show full text]
  • COVID-19 Situation Report 321
    For citation: Centre for Infectious Disease Epidemiology and Research-NUS. COVID-19 Situation Report 321. 16 December 2020 Dec 16 COVID-19 Situation Report 321 Centre for Infectious Disease Epidemiology and Research (CIDER) For citation: Centre for Infectious Disease Epidemiology and Research-NUS. COVID-19 Situation Report 321. 16 December 2020 i. Background In December, China notified the World Health Organization (WHO) of several cases of human respiratory illness, which appeared to be linked to an open seafood and livestock market in the city of Wuhan. The infecting agent has since been identified as a novel coronavirus, previously known as 2019-nCoV and now called SAR-CoV-2; The new name of the disease has also been termed COVID-19, as of 11th February 2020. Although the virus is presumed zoonotic in origin, person-to-person spread is evident. Screening of travellers, travel bans and quarantine measures are being implemented in many countries. Despite these precautions, it is anticipated that more cases will be seen both inside China and internationally. The WHO declared the outbreak of COVID-19 constitutes a Public Health Emergency of International Concern on 30 January. On 11 March, 2020, WHO declared the coronavirus outbreak a pandemic as the global death toll rose above 4,600 and the number of confirmed cases topped 125,000. This report aims to update Global Risk Assessment, Global Epidemiology, Quarantine Orders, Travel Ban/Advisory by countries, WHO’s and CDC’s Guidance and Protocols and Scientific publication on a daily basis. New updates in the tables are bolded. 1 | P a g e Centre for infectious di sease epidemiology and research For citation: Centre for Infectious Disease Epidemiology and Research-NUS.
    [Show full text]
  • From COVID-19 to Cancer Mrna Vaccines: Moving from Bench to Clinic in the Vaccine Landscape
    REVIEW published: 07 July 2021 doi: 10.3389/fimmu.2021.679344 From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape † † Chiranjib Chakraborty 1,2* , Ashish Ranjan Sharma 2 , Manojit Bhattacharya 3 and Sang-Soo Lee 2* 1 Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, India, 2 Institute for Skeletal Aging & Orthopedic Surgery, Hallym University-Chuncheon Sacred Heart Hospital, Chuncheon, Gangwon-do, South Korea, 3 Department of Zoology, Fakir Mohan University, Odisha, India Recently, mRNA vaccines have become a significant type of therapeutic and have created new fields in the biopharmaceutical industry. mRNA vaccines are promising next- generation vaccines that have introduced a new age in vaccinology. The recent Edited by: approval of two COVID-19 mRNA vaccines (mRNA-1273 and BNT162b2) has Bernard Verrier, accelerated mRNA vaccine technology and boosted the pharmaceutical and Centre National de la Recherche Scientifique (CNRS), France biotechnology industry. These mRNA vaccines will help to tackle COVID-19 pandemic Reviewed by: through immunization, offering considerable hope for future mRNA vaccines. Human trials Syafinaz Amin-Nordin, with data both from mRNA cancer vaccines and mRNA infectious disease vaccines have Universiti Putra Malaysia, Malaysia Wayne Robert Thomas, provided encouraging results, inspiring the pharmaceutical and biotechnology industries University of Western Australia, to focus on this area of research. In this article, we discuss current mRNA vaccines Australia broadly in two parts. In the first part, mRNA vaccines in general and COVID-19 mRNA *Correspondence: vaccines are discussed. We presented the mRNA vaccine structure in general, the Chiranjib Chakraborty [email protected] different delivery systems, the immune response, and the recent clinical trials for mRNA Sang-Soo Lee vaccines (both for cancer mRNA vaccines and different infectious diseases mRNA [email protected] vaccines).
    [Show full text]